| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000185904.7 |
Ponatinib |
Pancreatic adenocarcinoma |
0.043214347 |
Resistant |
| ENSG00000185904.7 |
Ponatinib |
Bladder urothelial carcinoma |
0.005849731 |
Sensitive |
| ENSG00000185904.7 |
Ponatinib |
Brain lower grade glioma |
0.027081364 |
Sensitive |
